1-9 of 9
Tianhong Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Double-Hit/Triple-Hit Myeloma: An Adverse Prognostic Factor That Can be Overcome By Minimal Residual Disease Negativity

Yang Yang, Wenjing Wang, Liang Ren, Yawen Wang, Aziguli Maihemaiti, Tianwei Lan, Chi Zhou, Panpan Li, Pu Wang, Jing Li, Jiadai Xu, Tianhong Xu, Fei-fei Chen, Peng Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6956.
https://doi.org/10.1182/blood-2024-207788
Published: 2024
Journal Articles

A Comparative Study of Clinical Characteristics, Cytogenetic Abnormalities and Outcomes Among Multiple Myeloma, Primary Light-Chain Amyloidosis and Multiple Myeloma with Concurrent AL Amyloidosis

Chenqi Yu, Jing Li, Tianhong Xu, Wenjing Wang, Pu Wang, Yang Yang, Peng Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2032.
https://doi.org/10.1182/blood-2023-188350
Published: 2023
Journal Articles

Exclusive Benefits of Sustained MRD-Negative in High-Risk Multiple Myeloma

Liang Ren, Tianhong Xu, Wenjing Wang, Yang Yang, Yawen Wang, Aziguli Maihemaiti, Tianwei Lan, Panpan Li, Chi Zhou, Pu Wang, Peng Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6663.
https://doi.org/10.1182/blood-2023-172450
Published: 2023
Journal Articles

Clinical Implication of Minimal Residual Disease By Multiparameter Flow Cytometry in Light Chain Amyloidosis

Tianhong Xu, Jing Li, Yang Yang, Wenjing Wang, Pu Wang, Chenqi Yu, Peng Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6770.
https://doi.org/10.1182/blood-2023-184754
Published: 2023
Journal Articles

Clinical Characterization of Hepatic Light Chain Amyloidosis in the Chinese Population: A Single-Center Retrospective Analysis

Chen Chen, Chenqi Yu, Jing Li, Weiguang Wang, Zhimei Wang, Lu-Ya Cheng, Fei-fei Chen, Jiadai Xu, Tianhong Xu, Yang Yang, Wenjing Wang, Pu Wang, Peng Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6745.
https://doi.org/10.1182/blood-2023-186600
Published: 2023
Journal Articles

Update on the Outcome of M-Protein Screening Program of Multiple Myeloma in China: A 7-Year Cohort Study

Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Peng Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10097–10098.
https://doi.org/10.1182/blood-2022-168200
Published: 2022
Journal Articles

The Efficacy and Safety Profile of Ixazomib-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma in Routine Clinical Practice: Real World Data from a Multi-Center Study in China

Jing Li, MD, Li Bao, Zhong-jun Xia, MD, Kaiyang Ding, Bingzong Li, MD PhD, Bing Chen, Zhengzheng Fu, Sili Wang, Wenhao Zhang, MD PhD, Xin Zhou, Luoming Hua, PhD, Wei Yang, Luo Jun, Liang Wang, Tianhong Xu, Yang Yang, Weida Wang, MD, Guolin Wu, Yun Huang, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5592.
https://doi.org/10.1182/blood-2019-130040
Published: 2019
Journal Articles

Ixazomib-Based Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma in Real-Life Practice Showed Comparable Efficacy and Safety Profile with Those Reported in Randomized Clinical Trials: A Multi-Center Study in China

Jing Li, MD, Li Bao, Zhong-jun Xia, MD, Sili Wang, Xin Zhou, Kaiyang Ding, Wenhao Zhang, MD PhD, Wei Yang, Bingzong Li, MD PhD, Zhengzheng Fu, Bing Chen, Luoming Hua, PhD, Liang Wang, Luo Jun, Yang Yang, Tianhong Xu, Weida Wang, MD, Yun Huang, Guolin Wu, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3181.
https://doi.org/10.1182/blood-2019-128614
Published: 2019
Journal Articles

Bone Marrow Tracer Uptake Pattern of PET/CT in Multiple Myeloma: Image Interpretation Criteria and Prognostic Value

Jing Li, MD, Hui Tan, PhD, Tianhong Xu, Hongcheng Shi, PhD, Peng Liu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1900.
https://doi.org/10.1182/blood-2018-99-114370
Published: 2018